Robert A. Smith, PhD, is a cancer epidemiologist and senior vice president of Early Cancer Detection Science for the American Cancer Society (ACS). For most of his tenure at the ACS, he has led the development of cancer screening guidelines and been active in research on the effectiveness of cancer screening, utilization of cancer screening, improving the quality of cancer screening, and new cancer screening technology.
Smith and his team focus on ensuring that ACS cancer screening guidelines rely on scientific evidence, meet high international standards of quality, and have the potential and aim to significantly reduce the burden of cancer.
They also track technical advances in screening technology and new approaches to early cancer detection so that the ACS can provide guidance on these new tests to clinicians and the public.
In addition to leading cancer screening guideline development, Smith is co-chair of the ACS National Colorectal Cancer Roundtable, and principal investigator of the ACS National Lung Cancer Roundtable. He has served and continues to serve on many US and international research and health policy advisory committees.
He has been a member of the Prevention Committees for three International Agency for Research on Cancer (IARC) Screening Handbooks (Breast, Colorectal, and Cervix), and presently serves on the Steering Committee of the International Cancer Screening Network.
Among his many recognitions and awards:
Dr. Smith serves on the editorial boards of the Journal of the National Cancer Institute and the Journal of Medical Screening and is journal referee for over 40 leading medical journals.
He has over 400 publications, including scientific articles, commentaries and editorials, book chapters, and reports. His articles have appeared in major clinical and epidemiology journals including Annals of Internal Medicine, CA: Cancer Journal for Clinicians, Cancer, Chest, JAMA, JNCI, Lancet, Lancet Oncology, NEJM, and Radiology.
For a list of his publications, visit his Google Scholar page.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.